Clinical Study of Novel CAR-ITNK Cells Targeting CD70 and CLL1 for Refractory/Relapsed AML
Clinical trial NCT07336875 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07336875
- Sponsor
- Tongji Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-28
- Primary completion
- 2028-02-28
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.